Holen Sie sich die Stockscreener-App
228.61
0.72%
1.64
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$226.97
Offen:
$227.85
24-Stunden-Volumen:
841.17K
Relative Volume:
1.50
Marktkapitalisierung:
$19.12B
Einnahmen:
$12.71B
Nettoeinkommen (Verlust:
$435.50M
KGV:
30.56
EPS:
7.48
Netto-Cashflow:
$843.20M
1W Leistung:
-1.47%
1M Leistung:
-3.88%
6M Leistung:
+10.24%
1J Leistung:
+3.82%
1-Tages-Spanne:
$226.56
$229.77
1-Wochen-Bereich:
$225.15
$233.97
52-Wochen-Spanne:
$191.97
$247.99
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Vergleichen Sie LH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
228.61 | 19.12B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Labcorp Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Labcorp Settles Competition Suit Against Ex-Sales Exec - Law360
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain? - Yahoo Finance
Labcorp Declares Quarterly Dividend - Kilgore News Herald
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal - MSN
Labcorp bird flu test takes flight - BioWorld Online
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians - Marketscreener.com
Labcorp releases H5 bird flu test as outbreak spreads By Investing.com - Investing.com Canada
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians – Company Announcement - Financial Times
Labcorp's SWOT analysis: new CFO, strong Q2 drive stock outlook By Investing.com - Investing.com Australia
Labcorp Agrees to Acquire Certain Legacy Health Outreach Laboratory Business Assets - Marketscreener.com
Labcorp's SWOT analysis: new CFO, strong Q2 drive stock outlook - Investing.com
Cell Free DNA (cfDNA) Testing Market Outlook to 2028 & 2033 - GlobeNewswire Inc.
Labcorp Forges Strategic Partnership with Tufts Medicine, Will A - GuruFocus.com
Labcorp closes takeover of Ballad Health outreach laboratory services - Yahoo Finance
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Labcorp Accuses Ex-Sales Exec Of Stealing Customers - Law360
Labcorp to Speak at the Baird 2024 Global Healthcare Conference - The Eastern Progress Online
In-Vitro Toxicology Testing Market Projected to Reach USD 30.06 Bn by 2033 - GlobeNewswire Inc.
Those who invested in Labcorp Holdings (NYSE:LH) five years ago are up 70% - Simply Wall St
Jefferies initiates Laboratory Corp with Buy, sets $275 target By Investing.com - Investing.com Canada
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health - The Eastern Progress Online
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test - The Eastern Progress Online
Labcorp Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Mercy BioAnalytics, Inc. announced that it expects to receive $59.999993 million in funding - Marketscreener.com
Insider Sell: Dwight Gilliland Sells 1,000 Shares of Labcorp Hol - GuruFocus.com
Labcorp director sells $241,000 in common stock - Investing.com
Labcorp executive sells $2.8 million in stock - Investing.com
Labcorp director sells $241,000 in common stock By Investing.com - Investing.com UK
Be Patient, Earn Dividends From Labcorp, The Leading Patient Clinical Lab Brand - Seeking Alpha
Labcorp to Acquire Select Assets From AtlantiCare - Marketscreener.com
Labcorp's EVP Amy Summy sells shares worth $877,141 By Investing.com - Investing.com Canada
Labcorp's EVP Amy Summy sells shares worth $877,141 - Investing.com India
Is Wall Street Bullish or Bearish on Labcorp Holdings Stock? - MSN
Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients - Yahoo Finance
Is Wall Street Bullish Or Bearish On Labcorp Holdings Stock? - Barchart
Labcorp's EVP Sandra van der Vaart sells $239,418 in stock - Investing.com India
Insider Sell: van der Vaart Sandra D Sells 1,000 Shares of Labco - GuruFocus.com
Labcorp's EVP Sandra van der Vaart sells $239,418 in stock By Investing.com - Investing.com Canada
At US$240, Is It Time To Put Labcorp Holdings Inc. (NYSE:LH) On Your Watch List? - Yahoo Finance
Ex-Dividend Reminder: Avista, Johnson & Johnson and Labcorp Holdings - Nasdaq
Three Days Left To Buy Labcorp Holdings Inc. (NYSE:LH) Before The Ex-Dividend Date - Simply Wall St
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):